Norway's Genetic Analysis Q1 gross margin hurt by US duties, currency impact

About this update from Genetic Analysis As

OverviewNorway diagnostics firm's Q1 sales revenue rose 60% yr/yr, driven by GA-map kit demandGross margin declined to 73.2% due to US customs duties and weaker USDCompany secured new patents in Canada and US, launched AI-assisted interpretation platformOutlookCompany did not provide specific guidance or financial outlook for the current qtr or yr in press releaseResult DriversREAGENT KIT SALES - Growth in recurring GA-map reagent kit sales drove Q1 revenue increaseCURRENCY AND DUTIES - Gross margin declined due to US customs duties and weaker USDCompany press release:Key DetailsMetricQ1 SalesBeat/MissActualNOK 3.8 mlnConsensus EstimateFor questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

View stock analysis, news, and events for Genetic Analysis As